INBX

Inhibrx Biosciences, Inc.

Phase 2 AI-extracted

ozekibart

colorectal cancer

Resolved

7days ago

Phase 2 readout · ~ Jun 30, 2026 estimated

What's at stake Phase 2 trial results for ozekibart in colorectal cancer are due ~ Jun 30, 2026. A clean hit validates the program; a miss can gap the stock down hard.

Primary source · SEC 8-K verified 13h ago

“We plan to announce progression-free survival (“PFS”) data for the Phase 1/2 colorectal cancer expansion cohort in the second quarter of 2026;”

Add to calendar Post on X Reddit

Provenance